Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN120518634A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iridium-catalyzed route offers high ee and yield for leukemia drug intermediates. Significant cost and supply chain advantages for global procurement.